Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1111/tri.13662 http://scihub22266oqcxt.onion/10.1111/tri.13662 32460390!7283727!32460390     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=32460390&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215 Deprecated: Implicit conversion from float 229.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 229.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Transpl+Int 2020 ; 33 (9): 1099-1105 Nephropedia Template TP {{tp|p=32460390|t=2020. COVID-19 in solid organ transplant recipients: a single-center experience |pdf=|usr=}}{{32460390}} gab.com Text COVID-19 in solid organ transplant recipients: a single-center experience JO: Transpl Int http://www.kidney.de/pget.php?&tw=1&pmid=32460390 #FOAvip Solid organ transplant (SOT) recipients may be at risk for severe COVID-19. Data on the clinical course of COVID-19 in immunosuppressed patients are limited, and the effective treatment strategy for these patients is unknown. We describe our institutional experience with COVID-19 in SOT. Demographic, clinical, and treatment data were extracted from the electronic patient files. A total of 23 SOT transplant recipients suffering from COVID-19 were identified (n = 3 heart; n = 15 kidney; n = 1 kidney-after-heart; n = 3 lung, and n = 1 liver transplant recipient). The presenting symptoms were similar to nonimmunocompromised patients. Eighty-three percent (19/23) of the patients required hospitalization, but only two of these were transferred to the intensive care unit. Five patients died from COVID-19; all had high Clinical Frailty Scores. In four of these patients, mechanical ventilation was deemed futile. In 57% of patients, the immunosuppressive therapy was not changed and only three patients were treated with chloroquine. Most patients recovered without experimental antiviral therapy. Modification of the immunosuppressive regimen alone could be a therapeutic option for SOT recipients suffering from moderate to severe COVID-19. Pre-existent frailty is associated with death from COVID-19. Twit Text FOAVip COVID-19 in solid organ transplant recipients: a single-center experience ????Transpl Int http://www.kidney.de/pget.php?&tw=1&pmid=32460390 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32460390 #FOAvip English Wikipedia <ref>{{Cite pmid|32460390}}</ref> COVID-19 in solid organ transplant recipients: a single-center experience #MMPMID32460390 Hoek RAS; Manintveld OC; Betjes MGH; Hellemons ME; Seghers L; Van Kampen JAA; Caliskan K; van de Wetering J; van den Hoogen M; Metselaar HJ; Hesselink DA Transpl Int 2020[Sep]; 33 (9): 1099-1105 PMID32460390show ga Solid organ transplant (SOT) recipients may be at risk for severe COVID-19. Data on the clinical course of COVID-19 in immunosuppressed patients are limited, and the effective treatment strategy for these patients is unknown. We describe our institutional experience with COVID-19 in SOT. Demographic, clinical, and treatment data were extracted from the electronic patient files. A total of 23 SOT transplant recipients suffering from COVID-19 were identified (n = 3 heart; n = 15 kidney; n = 1 kidney-after-heart; n = 3 lung, and n = 1 liver transplant recipient). The presenting symptoms were similar to nonimmunocompromised patients. Eighty-three percent (19/23) of the patients required hospitalization, but only two of these were transferred to the intensive care unit. Five patients died from COVID-19; all had high Clinical Frailty Scores. In four of these patients, mechanical ventilation was deemed futile. In 57% of patients, the immunosuppressive therapy was not changed and only three patients were treated with chloroquine. Most patients recovered without experimental antiviral therapy. Modification of the immunosuppressive regimen alone could be a therapeutic option for SOT recipients suffering from moderate to severe COVID-19. Pre-existent frailty is associated with death from COVID-19. |*Transplant Recipients[MESH] |Aged[MESH] |Aged, 80 and over[MESH] |COVID-19/*epidemiology/immunology/therapy[MESH] |Female[MESH] |Humans[MESH] |Immunosuppression Therapy/*adverse effects[MESH] |Male[MESH] |Middle Aged[MESH] |Netherlands/epidemiology[MESH] |Organ Transplantation/*adverse effects[MESH] |Pandemics[MESH] |SARS-CoV-2[MESH] |Treatment Outcome[MESH]COVID-19 in solid organ transplant recipients: a single-center experie(epmc).pdf DeepDyve Pubget Overpricing